Skip to content
Open access

Modeling and targeting haploinsufficiency in SHINE syndrome

Aug 2026 · bioRxiv · 0 citations · 48 references
Biology

TL;DR

These findings establish DLG4 haploinsufficiency as a shared consequence of pathogenic DLG4 variants, while revealing additional variant-associated effects on neuronal structure and activity, rescued by AAV9-mediated neuronal restoration.

Abstract

DLG4-related Synaptopathy, or SHINE syndrome, is a neurodevelopmental disorder caused by de novo heterozygous variants in DLG4 gene, encoding the postsynaptic scaffold PSD-95. Although clinical and genetic evidence support haploinsufficiency, the consequences of pathogenic DLG4 variants in human neurons remain poorly defined. Here, we model three mutations spanning distinct protein domains: a frameshift, nonsense and a missense mutation using iPSC-derived excitatory neurons. Molecular analysis of mature neurons reveals shared PSD-95 deficiency irrespective of transcript levels, together with reduced mature spine density. High-density microelectrode array recordings further reveal convergent and mutationspecific electrophysiological signatures at both single-neuron and network levels, as mutant cultures display genotype-dependent shifts in extracellular waveform states associated with altered firing dynamics. Importantly, restoration of PSD-95 levels using an adeno-associated viral vector (AAV9) harboring human DLG4 cDNA and driven by the human neuronal Synapsin I promoter (AAV9-hSynI-DLG4) rescues PSD95 abundance and associated cellular and electrophysiological deficits. Together, these findings establish DLG4 haploinsufficiency as a shared consequence of pathogenic DLG4 variants, while revealing additional variant-associated effects on neuronal structure and activity, rescued by AAV9-mediated neuronal restoration.

Read PDF

Similar papers

Open access Jun 2026

Characterization of Electrophysiological and Transcriptomic Alterations in Patient-Derived Neurons from CHAMP1 Syndrome

It is demonstrated that CHAMP1 mutations disrupt multiple aspects of neuronal development, including homologous recombination (HR) dysfunction in NPCs, membrane excitability, ion channel function, and synaptic connectivity.

Dailey Nettles, Christina Stanton, Z. Hunter et al. · 0 citations
Open access Aug 2026

Dominant truncating variants in KAT6A cause two neurodevelopmental disorders with opposite gene regulatory and metabolic changes.

Using patient-derived iPSCs and multi-omics profiling, it is demonstrated that early-truncating variants cause loss-of-function via nonsense-mediated decay (NMD), while late-truncating variants that escape NMD cause gain-of-function effects.

A. Nava, Y. Pérez-Rodríguez, T. Hsieh et al. · 0 citations
Aug 2026

Variants leading to ELAVL2 haploinsufficiency cause a neurodevelopmental disorder with prominent cognitive, behavioral, and neurological features.

An integrative study combining Mendelian genetics, clinical and association studies, and animal and molecular modeling supports variants in ELAVL2 as a cause of a neurodevelopmental disorder, with haploinsufficiency as the disease mechanism, and identifies crucial roles of ELAVL2 in neuronal function, cognition, and behavior.

Marina Boon, Meghan R. Mulligan, Jolijn J A Verseput et al. · 0 citations
Open access Jul 2026

SYNGAP1 haploinsufficiency disrupts early neurodevelopment and accelerates intrinsic neuronal maturation in human patient-derived models

It is demonstrated that SYNGAP1 haploinsufficiency disrupts early human brain development and accelerates intrinsic neuronal maturation, with pathogenic mechanisms emerging before synaptogenesis and extending beyond SYNGAP1’s established synaptic role.

Montanna Waters, Lucas Teasdale, Sean Byars et al. · 0 citations
Jul 2026

Arid1b haploinsufficiency in excitatory neurons alters neocortical circuits but not social behavior or seizure phenotypes.

In mice with conditional Arid1b haploinsufficiency in excitatory neurons, an increase in the rate of synaptic connectivity between excitatory neurons and reduced strength of excitatory synapses to parvalbumin (PV)-expressing inhibitory interneurons is found.

Alec H. Marshall, Meretta A. Hanson, Danielle J. Boyle et al. · 0 citations